Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ (1997) J Exp Med 185: 1705-10 Effect of salt supplementation on amphotericin B nephrotoxicity. Llanos A, Cieza J, Bernardo J, Echevarria J, Biaggioni I, Sabra R, Branch RA (1991) Kidney Int 40: 302-8 A critical, invariant chain-independent role for H2-M in antigen presentation. Swier K, Brown DR, Bird JJ, Martin WD, Van Kaer L, Reiner SL (1998) J Immunol 160: 540-4 Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S (2006) J Immunol 177: 3201-8 Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection. Roberts LJ, Baldwin TM, Speed TP, Handman E, Foote SJ (1999) Eur J Immunol 29: 3047-50 Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages. Misra S, Tripathi MK, Chaudhuri G (2005) J Biol Chem 280: 29364-73 Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. Rana T, Misra S, Mittal MK, Farrow AL, Wilson KT, Linton MF, Fazio S, Willis IM, Chaudhuri G (2011) J Biol Chem 286: 6614-26 Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum. Hargrove TY, Wawrzak Z, Liu J, Nes WD, Waterman MR, Lepesheva GI (2011) J Biol Chem 286: 26838-48 Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Lepesheva GI, Waterman MR (2011) Curr Top Med Chem 11: 2060-71 Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM, Foote SJ, Handman E (2004) Genes Immun 5: 93-100 Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine. Serezani CH, Franco AR, Wajc M, Umada Yokoyama-Yasunaka JK, Wunderlich G, Borges MM, Uliana SR (2002) Vaccine 20: 3755-63 Characterization of natural antimony resistance in Leishmania donovani isolates. Mittal MK, Rai S, Ashutosh , Ravinder , Gupta S, Sundar S, Goyal N (2007) Am J Trop Med Hyg 76: 681-8 A new standard for the assessment of disease progression in murine cutaneous leishmaniasis. Roberts LJ, Foote SJ, Handman E (2000) Parasite Immunol 22: 231-7 Reinfection in American cutaneous leishmaniasis: evaluation of clinical outcomes in the hamster model. Osorio Y, Gonzalez SJ, Gama VL, Travi BL (1998) Mem Inst Oswaldo Cruz 93: 353-6 Clonal diversity in the expression and stability of the metastatic capability of Leishmania guyanensis in the golden hamster. Martínez JE, Valderrama L, Gama V, Leiby DA, Saravia NG (2000) J Parasitol 86: 792-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.